BioSpace News Archive

Leading healthcare technology company implements machine learning-based self-service data platform to rapidly transform raw client data into reliable information to deliver better outcomes

Immunic, Inc. announced the appointment of Sanjay S. Patel, CFA, as Chief Financial Officer, effective July 15, 2019.

Amended agreement follows positive results in corn stalk rot fungal disease control

In April 2017, Crescita announced that it had entered into a development and commercialization license agreement with Taro Pharmaceuticals Inc.

Positions Firm for Next Phase of Growth and Development Following Successful 25-Year Track Record

Biofourmis’ innovative technology to measure patient-centric endpoints to inform future drug development

Soliton, Inc., a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center, announced that the company has submitted its pivotal cellulite clinical trial protocol for independent Institutional Review Board approval.

Ambrx Inc. announced that Bristol-Myers Squibb Company has initiated a phase I clinical trial to evaluate the safety, pharmacokinetics and pharmacodynamics of long-acting Relaxin for the potential treatment of heart failure.

-Highest Performing Early Stage Ovarian Cancer Risk Assessment Available Today-

Chronic sinusitis and bacteria-caused sinus infections are the most prevalent health issues witnessed in various countries.